DDi - Drug Development informatics – Trademark Portfolio
Entity Type: 16
DDi - Drug Development informatics holds 9 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 9 filings in this category. Currently, 6 trademarks are registered. Notable registered marks include MIRT, TULA, VISU, SMARTDOC, and PLEASE+PUBLISH. The owner is based in PRINCETON, NJ.
DDi
650 College Road East, SUITE # 3600
PRINCETON, NJ 08540
Showing of trademarks Trademarks
Trademark Classifications
DDi - Drug Development informatics's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does DDi - Drug Development informatics have?
DDi - Drug Development informatics has 9 U.S. trademarks filed with the USPTO. Of these, 6 registered, 1 abandoned, 2 cancelled.
What trademark classes does DDi - Drug Development informatics file in?
DDi - Drug Development informatics files trademarks across 1 Nice Classification class. The most active classes are Class 42 (Computer & Scientific). Class 42 covers scientific and technological services; industrial analysis and research services.
What are DDi - Drug Development informatics's most well-known trademarks?
DDi - Drug Development informatics's registered trademark portfolio includes well-known marks such as MIRT, TULA, VISU, SMARTDOC, and PLEASE+PUBLISH. These are among 6 currently registered trademarks in the portfolio.
What is DDi - Drug Development informatics's trademark registration success rate?
DDi - Drug Development informatics has a 67% trademark registration rate, with 6 out of 9 resolved applications resulting in successful registration. Currently, 0 applications are pending review.